Effects of Antimicrobial Prophylaxis and Blood Stream Infections inPatients With Acute Liver Failure: A Retrospective Cohort Study

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 11, 2014, Pages 1942-1949.e1

[No Author Info available]

Author keywords

Antibiotic; APAP; Compensatory Anti inflammatory Response Syndrome; Liver Damage; Systemic Inflammatory Response Syndrome

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CASPOFUNGIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; FLUCONAZOLE; GATIFLOXACIN; HYPERTENSIVE FACTOR; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; MICAFUNGIN; MOXIFLOXACIN; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TICARCILLIN; VANCOMYCIN;

ACUTE LIVER FAILURE; ADULT; AGE; ARTICLE; BLOODSTREAM INFECTION; COHORT ANALYSIS; COMA; COMATOSE PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EXPOSURE; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION PREVENTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SURGICAL MORTALITY; ANTIBIOTIC PROPHYLAXIS; COMPLICATION; MIDDLE AGED; MORTALITY; PROCEDURES; SEPSIS; SURVIVAL ANALYSIS; UNITED STATES;

ADULT; ANTIBIOTIC PROPHYLAXIS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEPSIS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84908259814     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.03.011     Document Type: Article

References (27)

1. Trewby P.N., Williams R. Pathophysiology of hypotension in patients with fulminant hepatic failure. Gut 1977, 18:1021-1026.
2. Antoniades C.G., Berry P.A., Wendon J.A., et al. The importance of immune dysfunction in determining outcome in acute liver failure. JHepatol 2008, 49:845-861.
3. Calandra T., Gerain J., Heumann D., et al. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 1991, 91:23-29.
4. Martin C., Boisson C., Haccoun M., et al. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997, 25:1813-1819.
5. Friedman G., Jankowski S., Marchant A., et al. Blood interleukin 10 levels parallel the severity of septic shock. JCrit Care 1997, 12:183-187.
6. Lehmann A.K., Halstensen A., Sornes S., et al. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun 1995, 63:2109-2112.
7. Wolk K., Docke W.D., von Baehr V., et al. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000, 96:218-223.
8. Sfeir T., Saha D.C., Astiz M., et al. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 2001, 29:129-133.
9. Rolando N., Wade J., Davalos M., et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000, 32:734-739.
10. Schmidt L.E., Larsen F.S. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 2006, 34:337-343.
11. Vaquero J., Polson J., Chung C., et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003, 125:755-764.
12. von Elm E., Altman D.G., Egger M., et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007, 335:806-808.
13. O'Grady J.G., Schalm S.W., Williams R. Acute liver failure: redefining the syndromes. Lancet 1993, 342:273-275.
14. Atterbury C.E., Maddrey W.C., Conn H.O. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 1978, 23:398-406.
15. Rolando N., Philpott-Howard J., Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996, 16:389-402.
16. Wyke R.J., Canalese J.C., Gimson A.E., et al. Bacteraemia in patients with fulminant hepatic failure. Liver 1982, 2:45-52.
17. Rolando N., Harvey F., Brahm J., et al. Fungal infection: a common, unrecognised complication of acute liver failure. JHepatol 1991, 12:1-9.
18. Wade J., Rolando N., Philpott-Howard J., et al. Timing and aetiology of bacterial infections in a liver intensive care unit. JHosp Infect 2003, 53:144-146.
19. Rolando N., Wade J.J., Fagan E., et al. An open, comparative trial of aztreonam with vancomycin and gentamicin with piperacillin in patients with fulminant hepatic failure. JAntimicrob Chemother 1992, 30:215-220.
20. Rolando N., Gimson A., Wade J., et al. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993, 17:196-201.
21. Rolando N., Wade J.J., Stangou A., et al. Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transpl Surg 1996, 2:8-13.
22. Karvellas C.J., Pink F., McPhail M., et al. Predictors of bacteraemia and mortality in patients with acute liver failure. Intensive Care Med 2009, 35:1390-1396.
23. Stravitz R.T. Critical management decisions in patients with acute liver failure. Chest 2008, 134:1092-1102.
24. Salmeron J.M., Tito L., Rimola A., et al. Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure. JHepatol 1992, 14:280-285.
25. Stravitz R.T., Kramer A.H., Davern T., et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007, 35:2498-2508.
26. Polson J., Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology 2005, 41:1179-1197.
27. Rolando N., Harvey F., Brahm J., et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990, 11:49-53.